CMPX vs PTC · $367.4M cap vs P/E 48, rev $2.74B
Compass Therapeutics Inc. (CMPX) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
PTC Inc (PTC) is a software - application company listed on US.
CMPX does not have a complete income-statement cache yet.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. Revenue was up 19.2% from 2024-09-30 to 2025-09-30. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
CMPX currently screens at market cap $367.4M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the CMPX and PTC stock pages for the full models.
Not investment advice.